ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,012, issued on Sept. 22, was assigned to SUNSHINE LAKE PHARMA Co. LTD. (Dongguan, China). "Humanized anti-TrkA antibodies and uses thereof... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,013, issued on Sept. 22, was assigned to Horizon Therapeutics Ireland DAC (Dublin). "IGF1R antibodies" was invented by Christopher Davidso... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,014, issued on Sept. 22, was assigned to FRESENIUS KABI DEUTSCHLAND GMBH (Bad Homburg, Germany). "Liquid pharmaceutical composition compri... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,015, issued on Sept. 22, was assigned to Ichnos Sciences SA (La Chaux-de-Fonds, Switzerland) and Astria Therapeutics Inc. (Boston). "Affin... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,016, issued on Sept. 22, was assigned to Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (Beijing) and National Cen... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,017, issued on Sept. 22, was assigned to Elixiron Immunotherapeutics (Hong Kong) Ltd. (Hong Kong, Hong Kong). "Anti-CD36 antibodies and us... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,018, issued on Sept. 22, was assigned to JANSSEN BIOTECH INC. (Horsham, Pa.). "Subcutaneous formulations of daratumumab and their uses in ... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,019, issued on Sept. 22, was assigned to Wisconsin Alumni Research Foundation (Madison, Wis.). "Antibodies targeting glioblastoma stem-lik... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,020, issued on Sept. 22, was assigned to Exuma Biotech Corp. (West Palm Beach, Fla.) and BioAtla Inc. (San Diego). "Chimeric antigen recep... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,021, issued on Sept. 22, was assigned to Children's Medical Center Corp. (Boston). "Inhibiting the RNA methyltransferase METTL3 or its int... Read More